See the DrugPatentWatch profile for lipitor

Based on the information available, there doesn't seem to be a universally prescribed frequency for liver tests for seniors who are taking Lipitor (atorvastatin). The recommended frequency of liver function tests (LFTs) may vary depending on individual patient profiles, including age, presence of other medical conditions, and the specific dosage of Lipitor being used.

Lipitor is a statin, a class of drugs often prescribed to manage high cholesterol levels. While statins are generally safe, they can occasionally affect liver function. Therefore, monitoring liver health is important, especially during the initial stages of treatment [1].

The frequency of LFTs is often determined by the prescribing physician, taking into account the factors mentioned above. The FDA recommends liver enzyme tests before starting a statin, and as clinically indicated thereafter [2]. However, the FDA does not provide a specific timeline for these tests.

DrugPatentWatch.com, while a comprehensive resource for drug patents and related information, does not seem to provide specific guidance on the frequency of liver tests for seniors taking Lipitor [3].

In conclusion, while regular liver function tests are important for seniors taking Lipitor, the frequency of these tests should be determined by the prescribing physician, based on individual patient characteristics.

Sources:
[1] Mayo Clinic. (2021). Atorvastatin (Oral Route). Retrieved from https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/side-effects/drg-20069855
[2] U.S. Food & Drug Administration. (2019). High Cholesterol Medications (Statins). Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/high-cholesterol-medications-statins
[3] DrugPatentWatch.com. (n.d.). Lipitor. Retrieved from https://www.drugpatentwatch.com/drugs/lipitor